BML Canada Limited
Michael Midmer
Investment Manager
Tel: 416.673.8443
E-mail: mm@bmicanada.com
Website: www.biosciencemanagers.com
Since 2001, BML has built a global network to serve the needs of the international life science sector. In addition to our in-house professionals, BML has an extensive network of clinicians, consultants and other industry experts to support our activities.
Investment Manager
Tel: 416.673.8443
E-mail: mm@bmicanada.com
Website: www.biosciencemanagers.com
Since 2001, BML has built a global network to serve the needs of the international life science sector. In addition to our in-house professionals, BML has an extensive network of clinicians, consultants and other industry experts to support our activities.
BML has a multidisciplinary professional team bringing together diverse backgrounds in science, medicine, business, law and finance along with accomplished professional careers in venture capital, academia and the biotechnology and pharmaceutical industries. The team has held senior management roles in R&D, sales and marketing, operations and strategy and is complemented by a prestigious network of advisors.
BROWSE TENANTS
- AIM Therapeutics Inc.
- Ambit Biosciences
- ApoPharma Inc.
- ArcticDx Inc.
- AstraZeneca Canada Inc.
- Axela Inc.
- AXS Biomedical Animation Studio
- BioDiscovery Toronto
- BioFinance Canada
- BioQuest Innovations Inc.
- Biosign Technologies Inc.
- The Biotechnology Initiative
- BML Canada Limited
- Canadian Biotechnology Education Resource Centre (CBERC)
- Cascade Therapeutics Inc.
- Cassandra Capital L.P.
- Celtic House Venture Partners
- Clera Inc.
- Constab International Inc.
- Critical Outcome Technologies Inc.
- CVCA - Canada’s Venture Capital & Private Equity Association
- Diagnostic Systems Laboratories
- GlaxoSmithKline Inc.
- htx.ca - The Health Technology Exchange
- The Innovations Group, University of Toronto
- iLOOKABOUT Inc.
- Innovation Institute of Ontario
- Interface Biologics
- InVisage Technologies
- In Vitro Drug Safety & BioTechnology
- Kanata Chemical Technologies
- Larial Proteomics
- MaRS Landing
- The Martin Prosperity Institute
- McLaughlin Centre for Molecular Medicine
- McLaughlin-Rotman Centre for Global Health - Program on Life Sciences, Ethics and Policy
- Merck Frosst Canada Ltd.
- NeurAxon Inc.
- Ontario Cancer Biomarker Network (OCBN)
- Octopz Inc.
- Ogilvy Renault LLP
- Ontario Institute for Cancer Research
- Ontario Geonomics Institute
- Ontario Innovation Trust
- Ontario Society for Excellence in Techology Transfer
- Ozmosis Research
- RBC Royal Bank
- RBC Venture Partners
- Receptor Therapeutics Inc.
- Sigma Analysis & Management Ltd.
- Skymeter Corporation
- Toronto Region Research Alliance
- Transition Therapeutics
- University Hospital Network Technology Development & Commercialization Office
- University Health Network
- University of Toronto Asset Management Corporation
- University of Waterloo
- YYZ/Blue Sky Capital Corporation